Table 1.
Dose (µM) | |||
---|---|---|---|
Compound | 10 | 25 | 50 |
SFN | 117.0 ± 13.1 | 101.8 ± 11.4 | 69.6 ± 9.51 * |
SNB | 123.9 ± 13.5 | 122.9 ± 8.8 | 126.6 ± 10.2 |
Di-CQA | 138.5 ± 4.4 | 130.9 ± 8.4 | 120.2 ± 8.7 |
Cy3,5DiG | 117.9 ± 5.7 | 106.5 ± 7.1 | 95.5 ± 6.8 |
Results represent viability (%) as the mean ± SEM following 24 h exposure of HL-60 differentiated cells to the tested compounds at the different doses indicated plus LPS (0.1 µg/mL). Data were obtained from three different assays (N = 3). * p < 0.05. Cy3,5DiG: cyanidin-3,5-diglucoside; Di-CQA: di-caffeoylquinic acid; SFN: sulforaphane; SNB: sinalbin.